Literature DB >> 18201569

Origin and evolution of the c.844_845ins68/c.833T>C mutations within the cystathionine beta-synthase gene in great apes.

Maurizio Romano1, Maria Giulia Bacalini, Ernst J Verschoor, Sergio Crovella, Francisco E Baralle.   

Abstract

The c.[833C; 844_845ins68] is a common haplotype of the human cystathionine beta-synthase gene among healthy individuals. This polymorphism (5-40% allelic frequency in different populations) consists of the c.844_845ins68 insertion that segregates in cis with the pathogenic c.833T>C substitution (p.I278T). Through genotyping of primates, we have found that gorillas, chimpanzees and bonobos are homozygous for the 68bp insertion, c.844_845ins68. In gorillas and bonobos, the c.844_845ins68 lesion segregates in cis with the wild-type c.833T variant, whilst chimpanzees present the human haplotype. These genetic evidences suggest that the origin of the 68bp insertion might be dated back to 6-8 million years ago, and that the c.833T>C substitution occurred within the allele carrying the insertion. The evolutionary conservation of this peculiar haplotype supports the hypothesis of its protective effects against cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18201569     DOI: 10.1016/j.febslet.2007.12.038

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  Characterisation of a human liver cystathionine beta synthase mRNA sequence corresponding to the c.[833T>C;844_845ins68] mutation in CBS gene.

Authors:  Jean-François Chassé; Robert Barouki
Journal:  Mol Cell Biochem       Date:  2009-07-11       Impact factor: 3.396

2.  A customized scaffolds approach for the detection and phasing of complex variants by next-generation sequencing.

Authors:  Qiandong Zeng; Natalia T Leach; Zhaoqing Zhou; Hui Zhu; Jean A Smith; Lynne S Rosenblum; Angela Kenyon; Ruth A Heim; Marcia Eisenberg; Stanley Letovsky; Patricia M Okamoto
Journal:  Sci Rep       Date:  2020-09-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.